Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2386 (LINC02386) is a human long non-coding RNA (lncRNA) gene that does not code for a protein. It is classified as a long intergenic non-coding RNA (lincRNA), which means it is transcribed from genomic regions located between protein-coding genes and does not overlap with them. LINC02386 is cataloged in gene databases including NCBI Gene (ID: 105369717) and Ensembl (ENSG00000257756). LincRNAs such as LINC02386 generally function in regulation of gene expression, chromatin remodeling, transcriptional modulation, and possibly mRNA processing. While dysregulation of lncRNAs has been implicated in various diseases such as cancer, cardiovascular, and autoimmune diseases, there are no specific reports connecting LINC02386 itself to therapeutic targeting, drug interactions, biomarker roles, or clinical safety concerns at this time. Thus, LINC02386 represents part of a broad and not yet fully characterized class of regulatory RNAs that can influence cellular processes, but for this specific lincRNA, available data do not support its consideration as a defined therapeutic target, enzyme, transporter, or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2386 (LINC02386).